Immunity in the first year of life and call for vaccination

  • Authors

    • Sunil Shewale Ex.Officer-Clinical Trials Serum Institute of India Ltd. India.
    • Sameer Parekh Project Manager-Clinical Trials Serum Institute of India Ltd. India.
    2014-07-09
    https://doi.org/10.14419/ijbr.v2i2.2923

  • Abstract

    Children present special needs because of their vulnerability and developmental peculiarities. Early stage protection is critical in children and the immunization in the first year is especially important. Hence to protect them against some of the most dangerous diseases during and beyond the first year of life, it is essential that infants should get all recommended vaccines at the right time. The vaccines work by building up the child's defense mechanism against diseases. Some vaccines require multiple doses for full protection and every child thus, must complete particular immunization schedule. A child who is not immunized is more likely to become sick, permanently disabled or undernourished, and could possibly die. This article explores the current knowledge about the importance of immunity before and after the beginning of human life and reviews the essential vaccines for infancy. It will ultimately help to explore science of immunology and vaccinology.

    Keywords: Infants, Infectious Diseases, Immunity, Immunization, Vaccine.

  • References

    1. LF & Hussey G (2011) World Health Organization the Immu-nological Basis for Immunization Series Module 5: Tuberculosis, p 1-29.
    2. Borrow R, Balmer P & Roper MH (2007) World Health Organ-ization The Immunological Basis for Immunization Series Module 3: Tetanus (Revision), p 1-52.
    3. Committee on Infectious Diseases. United States (2002) Recommended Childhood Immunization Schedule. Pediatrics 109(1), p 162. (DOI: 10.1542/peds.109.1.162).
    4. Farley MM, Stephens DS, Brachman PS, Harvey RC, Smith JD, Wenger JD & CDC Meningitis Surveillance Group (1992) Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. Annals of Internal Medicine 116(10), p 806-812. (DOI: 10.7326/0003-4819-116-10-806)
    5. Gleeson M & Cripps AW (2004) Development of mucosal immunity in the first year of life and relationship to sudden infant death syndrome. FEMS Immunology and Medical Microbiology 42(1), p 21–33. (DOI: 10.1016/j.femsim.2004.06.012).
    6. Gudmundsdotter L & Hallengard D (2008) Challenges of Global Vaccine Development. Expert Rev. Vaccines 7(1), p 21-23. (DOI: 10.1586/14760584.7.1.21.)
    7. Hanson LA (1998) Breastfeeding provides passive and likely long-lasting active immunity. Ann Allergy Asthma Immunol. 81(6), p 523-33; quiz 533-4, 537. (DOI: http://dx.doi.org/10.1016/S1081-1206(10)62704-4)
    8. Jefferson T, Rudin M & Dipietrantonj C (2003) Systematic review of the effects of DTP vaccines in children. Vaccine 21, p 2012-2023.
    9. Käyhty H, Nurkka A, Soininen A, Väkeväinen M (2009) World Health Organization The Immunological Basis for Immunization Series Module 12: Pneumococcal vaccines, p 1-50.
    10. Lehmann D, Pomat WS, Combs B, Dyke T & Alpers MP (2002) maternal immunization with pneumococcal polysaccharide vaccine in the highlands of Papua New Guinea. Vaccine 20, p 1837–1845.
    11. McCool TL, Clifford VH, Greenspan NS & Schreiber JR (1999) B- and T-Cell Immune Responses to Pneumococcal Conjugate Vaccines: Divergence between Carrier- and Polysaccharide-Specific Immunogenicity. Infect. Immun. 67(9), p 4862-4869.
    12. Nicole R, Willem H, Roy R, Warwick B & Nigel C (2008) Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiology Reviews 32(5), p 821–841. (DOI: 10.1111/j.1574-6976.2008.00118.x).
    13. Ovsyannikova IG, Dhiman N, Jacobson RM, Vierkant RA & Poland GA (2003) Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine. Clin Diagn Lab Immunol 10(3), p 411-416. (DOI: 10.1128/CDLI.10.3.411–416.2003)
    14. Palmeira P, Quinello C, Silveira-Lessa A, Zago C & Carneiro-Sampaio M (2012) IgG Placental Transfer in Healthy and Pathological Pregnancies. Clinical and Developmental Immunology 2012, p 1-13. (DOI:10.1155/2012/985646).
    15. Paul F, Ken E & Heymann DL (2011) Herd Immunity: A Rough Guide. Clin Infect Dis. 52(7), p 911-916. (DOI: 10.1093/cid/cir007).
    16. Robertson S (1993) World Health Organization the Immunological Basis for Immunization Series Module 6: Poli-omyelitis, p 1-24.
    17. Rowe JH, Ertelt JM, Xin L & Way SS (2012) Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 490, p 102-106. (DOI: 10.1038/nature11462).
    18. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, López P, Macías-Parra M, Ortega-Barría E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavía-Ruz N, Salmerón J, Rüttimann R, Tinoco JC, Rubio P, Nuñez E, Guerrero ML, Yarzábal JP, Damaso S, Tornieporth N, Sáez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, Vos B & O'Ryan M (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. New England Journal of Medicine 354, p 11-22. (DOI: 10.1056/NEJMoa052434).
    19. Scheifele DW & Ochnio JJ (2009) World Health Organization The Immunological Basis for Immunization Series Module 2: Diphtheria, p 1-28.
    20. Stevenk O, Steinhoff MC, Shahid N & Siber G (1996) Serum, breast milk, and infant antibody after maternal immunization with pneumococcal vaccine. Lancet 347(8995), p 192-93. (DOI: 10.1016/S0140-6736(96)90376-1).
    21. Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA & Skoff TH (2013) Waning Immunity to Pertussis Following 5 Doses of DTaP. Pediatrics 131(4), p e1047-e1052. (DOI:10.1542/peds.2012-1928).
    22. Unicef Immunization. Expanding Immunization Coverage. Available at: http://www.unicef.org/immunization/index_coverage.html (Ac-cessed 1 July, 2014).
    23. Vesikari T, Giaquinto C & Huppertz H (2006) Clinical trials of rotavirus vaccines in Europe. Pediatric Infectious Disease Journal 25, p S42-S47. (DOI: 10.1097/01.inf.0000197565.45345.4e)
    24. Ward RL & Bernstein DI (2011) World Health Or-ganization The Immunological Basis for Immunization Series Module 21: Rotavirus, p 1-48.
    25. Watson JC, Pearson JA, Markowitz LE, Baughman AL, Erdman DD, Bellini WJ Baron RC & Fleming DW (1996) An evaluation of measles revaccination among school-entry-aged children. Pediatric 97(5), p 613-618.
    26. Weiner C, Pan Q, Hurtig M, Borén T, Bostwick E & Ham-marström L (1999) Passive immunity against human pathogens using bovine antibodies. Clin Exp Immunol. 116, p 193–205. (DOI: 10.1046/j.1365-2249.1999.00880.x).
    27. Wong-C RM, Islas-Romero R, Garcia-Garcia ML, Beeler JA, Audet S, Santos-Preciado JI, Gans H, Lew-Yasukawa L, Maldonado Y, Arvin AM & Valdespino-Gomez JL (2004) Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children. J Infect Dis 189(2), p 254-257. (DOI: 10.1086/380565)
    28. World Health Organization (2007) Technical Report Series No. 941 Annex 6 Recommendations for whole-cell pertussis vaccine, p 301-333.
    29. World Health Organization Technical Report Series (TRS), 615 (1977) the selection of essential drugs. Report of a WHO Expert Committee Geneva, p 1-36.
    30. World Health Organization Technical Report Series (TRS), 895 (2000) the use of essential drugs, 9th Report of the WHO Expert Committee Geneva, p 1-68.
    31. World Health Organization Weekly Epidemiological Record (WER) (2006) Japanese encephalitis 81, p 325-340.
    32. World Health Organization Weekly Epidemiological Record (WER) (2010) Rabies 85, p 309-320.
    33. World Health Organization Weekly Epidemiological Record (WER) (2011) Rubella 86, p 301-316.
    34. World Health Organization Weekly Epidemiological Record (WER) (2006) Diphtheria 81, p 21-32.
    35. World Health Organization Weekly Epidemiological Record (WER) (2006) Measles 81, p 21-32.
    36. World Health Organization Weekly Epidemiological Record (WER) (2006) Tetanus 81, p 197-208.
    37. World Health Organization Weekly Epidemiological Record (WER) (2010) Pertussis 85, p 385-400.
    38. World Health Organization Weekly Epidemiological Record (WER) (2010) Polio vaccines and polio immunization in the pre-eradication era 85, p 213-228.
    39. World Health Organization Weekly Epidemiological Record (WER) (2004) BCG 79, p 25-40.
    40. World Health Organization Weekly Epidemiological Record (WER) (2009) Hepatitis B 84, p 405-420.
    41. Zinkernagel RM (2000) on immunological memory. Philos Trans R Soc Lond B Biol Sci. 355(1395), p 369-371. (DOI: 10.1098/rstb.2000.0576)
    42. Zinkernagel RM (2001) maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med. 345(18), p 1331-1335. (DOI: 10.1056/NEJMra012493)
    43. Zinkernagel RM, Bachmann MF, Kündig TM, Oehen S, Pirchet H & Hengartner H (1996) On immunological memory. Annu Rev Immunol 14, p 333-367. (DOI: 10.1146/annurev.immunol.14.1.333)
    44. Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D & Pai M (2011) The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices. PLoS Med. 8(3), p e1001012. (DOI: 10.1371/journal.pmed.1001012).

  • Downloads

  • How to Cite

    Shewale, S., & Parekh, S. (2014). Immunity in the first year of life and call for vaccination. International Journal of Biological Research, 2(2), 61-66. https://doi.org/10.14419/ijbr.v2i2.2923

    Received date: 2014-05-26

    Accepted date: 2014-06-30

    Published date: 2014-07-09